Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  New England Journal of Medicine

• Publication date

  2001-06-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1062-1458(01)00460-3PMID 11430324
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.

  2001cited by this paper
• High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.

  2001cited by this paper
• Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary Hypercholesterolemia

  2001cited by this paper
• Pleiotropic effects of statins

  2000cited by this paper
• Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

  2000cited by this paper
• Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia.

  2000cited by this paper
• Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

  2000cited by this paper
• The New England Journal

  2000cited by this paper
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000cited by this paper
• Using Cost-Effectiveness Analysis To Target Cholesterol Reduction

  2000cited by this paper
• Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

  1999cited by this paper
• Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

  1999cited by this paper
• C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

  1999cited by this paper
• Clinical efficacy of an automated high-sensitivity C-reactive protein assay.

  1999cited by this paper
• Bee sting dysphagia.

  1999cited by this paper
• Elevated C-reactive protein levels in overweight and obese adults.

  1999cited by this paper
• Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

  1998cited by this paper
• Maximizing the cost-effectiveness of lipid-lowering therapy.

  1998cited by this paper
• Atherosclerosis is an Inflammatory Disease

  1998cited by this paper
• Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.

  1997cited by this paper
• Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

  1997cited by this paper
• Molecular bases of the acute coronary syndromes.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

  1993cited by this paper
• Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.

  1991cited by this paper

• Triglyceride-Rich Lipoproteins and Inflammation: Independent and Synergistic Roles in Cardiovascular Disease

  2026cites this paper
• Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology.

  2025cites this paper
• T cells in cardiovascular disease: solved and unsolved mysteries

  2025cites this paper
• Diagnostic and Prognostic Roles of Inflammatory Biomarkers in Patients With Coronary Heart Disease and Heart Failure Treated With Empagliflozin.

  2025cites this paper
• High-sensitivity C-reactive protein and its role in coronary atherosclerotic disease: a review of current literature.

  2025cites this paper
• Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident stroke in middle-aged and older Chinese adults: a longitudinal analysis based on CHARLS

  2025cites this paper
• Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors along with colchicine versus colchicine alone among coronary artery disease and type 2 diabetes patients.

  2025cites this paper
• Elevated Alcohol Consumption and Chronic Inflammation Predict Cardiovascular Risk Among Black Americans: Examination of a Dual-Risk Model Using Epigenetic Risk Markers

  2025cites this paper
• Association between hemoglobin-to-red blood cell distribution width ratio and cognitive impairment in elderly Americans

  2025cites this paper
• Statin Use is Associated With Lower Odds of IBD-Related Surgery Among Patients With Moderate-to-Severe Inflammatory Bowel Disease.

  2025cites this paper
• Non-Traditional Cardiovascular Risk Factors: Tailored Assessment and Clinical Implications

  2025cites this paper
• C-reactive protein exacerbates high-fat diet-induced atherosclerosis via a liver-to-vessel axis that determines therapeutic efficacy of atorvastatin.

  2025cites this paper
• Influence of circadian alignment and sleep timing variability on sex-specific inflammatory markers in healthy adults.

  2025cites this paper
• The high-sensitivity C-reactive protein to lymphocyte ratio is associated with all-cause and cardiovascular mortality in U.S. adults: A cohort study from NHANES 2015 to 2018

  2025cites this paper
• Association of hemoglobin and red cell distribution width ratio with new cardiovascular events in peritoneal dialysis patients.

  2025cites this paper
• Dyslipidemia and statin use in people with HIV-1 infection: beyond the lipid-lowering effect.

  2025cites this paper
• The Role of C-Reactive Protein in Acute Myocardial Infarction: Unmasking Diagnostic, Prognostic, and Therapeutic Insights

  2025cites this paper
• Statin Therapy as Primary Prevention for Persons With HIV: A Synopsis of Recommendations From the U.S. Department of Health and Human Services Antiretroviral Treatment Guidelines Panel.

  2025cites this paper
• How Exercise Affects Exerkines in Metabolic Syndrome

  2025cites this paper
• Colchicine for cardiovascular and limb risk reduction in Medicare beneficiaries with peripheral artery disease: emulation of target trials

  2024cites this paper
• Association between long-term statin use and cataract surgery: a nationwide study on 505 105 cataract surgery patients

  2024cites this paper
• Efficacy, safety and adherence of high intensity interval training and remote ischemic pre-condition among coronary artery disease patients: a study protocol

  2024cites this paper
• Novel Systemic Inflammatory Markers Predict All-Cause Mortality in Patients Undergoing Endovascular Abdominal Aortic Aneurysm Repair

  2024cites this paper
• Effects of statins beyond lipid-lowering agents in ART-treated HIV infection

  2024cites this paper
• Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs.

  2024cites this paper
• Nattokinase attenuates endothelial inflammation through the activation of SRF and THBS1.

  2024cites this paper
• The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review

  2024cites this paper
• Exploring the Landscape of Anti-Inflammatory Trials: A Comprehensive Review of Strategies for Targeting Inflammation in Acute Myocardial Infraction

  2024cites this paper
• Proteína C reactiva, aspectos cardiovasculares de una proteína de fase aguda: una actualización para el médico

  2024cites this paper
• Assessment of Efficacy and Adverse Effects of Atorvastatin and Rosuvastatin in Dyslipidemia Treatment in a Tartary Care Hospital

  2024cites this paper
• The Role of Inflammation in Early Left Ventricular Thrombus Formation Following ST‐Elevation Myocardial Infarction—A Matched Case‐Control Study

  2024cites this paper
• Hemoglobin-to-red blood cell distribution width ratio is negatively associated with stroke: a cross-sectional study from NHANES

  2024cites this paper
• Comparison of interleukin-6 and high-sensitivity C-reactive protein for cardiovascular risk assessment: Findings from the MESA study.

  2024cites this paper
• Colchicine and cardiovascular prevention.

  2024cites this paper
• The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review

  2023cites this paper
• The Cardiovascular Risks Associated with Aromatase Inhibitors, Tamoxifen, and GnRH Agonists in Women with Breast Cancer

  2023cites this paper
• A bidirectional Mendelian randomized study of classical blood lipids and venous thrombosis

  2023cites this paper
• Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers

  2023cites this paper
• Lipoprotein (a), Inflammation, and Atherosclerosis

  2023cites this paper
• Statins Modulate Microenvironmental Cues Driving Macrophage Polarization in Simulated Periodontal Inflammation

  2023cites this paper
• Multifaceted role of cardiovascular biomarkers.

  2023cites this paper
• C-Reactive Protein: The Quintessential Marker of Systemic Inflammation in Coronary Artery Disease—Advancing toward Precision Medicine

  2023cites this paper
• Predictive role of monocyte count for significant coronary artery disease identification in patients with stable coronary artery disease

  2023cites this paper
• Hemoglobin to red cell distribution width ratio as a prognostic marker for ischemic stroke after mechanical thrombectomy

  2023cites this paper
• Inflammation in Cardiovascular Disease: Current Status and Future Perspectives

  2023cites this paper
• Anti-inflammatory therapy in atherosclerotic cardiovascular disease: Current reappraisal

  2023cites this paper
• Review of plaque characteristics in individuals with sudden coronary death.

  2023cites this paper
• Prevalence of Thromboembolic Events, Including Venous Thromboembolism and Arterial Thrombosis, in Patients with COVID-19: A Systematic Review with Meta-Analysis

  2023cites this paper
• Importance of assessment of carotid plaques in the managementof acute ischemic stroke: floating intracarotid plaque

  2023cites this paper
• The efficacy of statins in the treatment of rheumatoid arthritis: A systematic review and meta-analysis

  2023cites this paper
• QUANTIFICATION OF CRP, DIFFERENTIAL COUNT AND BLOOD SUGAR IN ACUTE CORONARY SYNDROME

  2023cites this paper
• An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk.

  2023cites this paper
• Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic of the Week.

  2023cites this paper
• Interleukin-6 signaling in atherosclerosis: from molecular mechanisms to clinical outcomes.

  2023cites this paper
• Association between hemoglobin-to-red blood cell distribution width ratio and hospital mortality in patients with non-traumatic subarachnoid hemorrhage

  2023cites this paper
• A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia

  2023cites this paper
• The Effect of Physical Activity on Arterial Stiffness, Inflammation and Lipoproteins among 30–65-Year-Old Men

  2023cites this paper
• HS‐CRP Modifies the Prognostic Value of Platelet Count for Clinical Outcomes After Ischemic Stroke

  2023cites this paper
• Targeting inflammation to reduce recurrent stroke

  2023cites this paper
• Anti-inflammatory Therapy Progress in Major Adverse Cardiac Events after PCI: Chinese and Western Medicine

  2023cites this paper
• ASSOCIATION BETWEEN C - REACTIVE PROTEIN AND FASTING BLOOD GLUCOSE IN TYPE 2 DIABETES MELLITUS PATIENTS

  2023cites this paper
• Translational Molecular Imaging Tool of Vulnerable Carotid Plaque: Evaluate Effects of Statin Therapy on Plaque Inflammation and American Heart Association–Defined Risk Levels in Cuff-Implanted Apolipoprotein E–Deficient Mice

  2022cites this paper
• Pharmaco-invasive therapy: Early implementation of statins and proprotein convertase subtilisin/kexin type 9 inhibitors after acute coronary syndrome

  2022cites this paper
• Effects of High- or Moderate-intensity Rosuvastatin on 1-year Major Adverse Cardiovascular Events Post-percutaneous Coronary Intervention

  2022cites this paper
• Improvement of clinical outcomes in patients undergoing peritoneal dialysis using hydroxymethylglutaryl-CoA reductase inhibitors: A systematic review and meta-analysis

  2022cites this paper
• Importance of Intermittent Fasting Regimens and Selection of Adequate Therapy on Inflammation and Oxidative Stress in SARS-CoV-2 Infection

  2022cites this paper
• Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients

  2022cites this paper
• Role of Sex in Atherosclerosis: Does Sex Matter?

  2022cites this paper
• Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial

  2022cites this paper
• Research Landscape on Atherosclerotic Cardiovascular Disease and Inflammation: A Bibliometric and Visualized Study

  2022cites this paper
• Red cell distribution width and Glasgow coma scale score as predictors of in-hospital mortality in maintenance hemodialysis patients diagnosed with spontaneous intracerebral hemorrhage

  2022cites this paper
• Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases

  2022cites this paper
• Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations

  2022cites this paper
• Relationship between the Hemoglobin-to-Red Cell Distribution Width Ratio and All-Cause Mortality in Septic Patients with Atrial Fibrillation: Based on Propensity Score Matching Method

  2022cites this paper
• Association of Serum γ-Glutamyltransferase With C-Reactive Protein Levels in Patients With Coronary Heart Disease

  2022cites this paper
• Actualités dans la physiopathologie de l'athérosclérose

  2022cites this paper
• Colchicine for Coronary Artery Disease: A Review

  2022cites this paper
• Acute Myocardial Infarction (AMI) as the Effect Modifiers to Modify the Association Between Red Blood Cell Distribution Width (RDW) and Mortality in Critically Ill Patients With Stroke

  2022cites this paper
• Treatment and Outcome of Castleman Disease: A Retrospective Report of 31 Patients

  2022cites this paper
• The effect of various types and doses of statins on C-reactive protein levels in patients with dyslipidemia or coronary heart disease: A systematic review and network meta-analysis

  2022cites this paper
• Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement

  2022cites this paper
• A Dietitian-Led Vegan Program May Improve GlycA, and Other Novel and Traditional Cardiometabolic Risk Factors in Patients With Dyslipidemia: A Pilot Study

  2022cites this paper
• The Prediction of Cardiac Events Using Contemporary Risk Prediction Models after Radiation Therapy for Head and Neck Cancer

  2022cites this paper
• Using Genomic data to Investigate the Anti-Depressive Effects of Statins

  2022cites this paper
• Effect of Trichilia monadelpha (Thonn.) J. J. de Wilde (Meliaceae) extracts on C-reactive proteins levels and acute inflammation

  2022cites this paper
• Hemoglobin-to-Red-Cell Distribution Width Ratio Is a Novel Predictor of Long-Term Patient Outcomes After Percutaneous Coronary Intervention: A Retrospective Cohort Study

  2022cites this paper
• Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention

  2022cites this paper
• Evaluation of Asymmetric Dimethylarginine Serum Level and Left Ventricular Function by 2D Speckle Tracking Echocardiography in Children on Regular Hemodialysis.

  2022cites this paper
• Longitudinal High-Sensitivity C-Reactive Protein and Longer-Term Cardiovascular Outcomes in Optimally-Treated Patients With High-Risk Vascular Disease.

  2022cites this paper
• Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases

  2022cites this paper
• The role of inflammation and the possibilities of inflammation reduction to prevent cardiovascular events

  2022cites this paper
• The Effect of Statins on C-Reactive Protein in Stroke Patients: A Systematic Review of Clinical Trials

  2021cites this paper
• Repeated In-Stent Restenosis Despite Aggressive Lipid Loweringby PCSK-9 Inhibitor Treatment: A Case Report.

  2021cites this paper
• HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study

  2021cites this paper
• Inflammation and Cardiovascular Disease: The Future

  2021cites this paper
• Triglycerides and Residual Atherosclerotic Risk

  2021cites this paper
• Heterogeneous subpopulations of adventitial progenitor cells regulate vascular homeostasis and pathological vascular remodeling.

  2021cites this paper
• Plausible Positive Effects of Statins in COVID-19 Patient

  2021cites this paper
• The Role of C-reactive Protein in Patient Risk Stratification and Treatment

  2021cites this paper
• Potential Impact of Statins on Neuronal Stress Responses in Patients at Risk for Cardiovascular Disease

  2021cites this paper